Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124935146 | 12493514 | 6 | F | 20160718 | 20160623 | 20160725 | EXP | GB-WATSON-2016-13004 | ACTAVIS | 0.00 | F | Y | 0.00000 | 20160725 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124935146 | 12493514 | 1 | SS | Carboplatin (Unknown) | CARBOPLATIN | 1 | Unknown | UNK | U | UNCONFIRMED | 0 | UNK | |||||||
124935146 | 12493514 | 2 | PS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK | U | UNCONFIRMED | 79160 | UNK | |||||||
124935146 | 12493514 | 3 | SS | VINORELBINE | VINORELBINEVINORELBINE TARTRATE | 1 | Unknown | UNK | U | UNCONFIRMED | 0 | UNK | |||||||
124935146 | 12493514 | 4 | SS | Capecitabine (Unknown) | CAPECITABINE | 1 | Unknown | UNK | U | UNCONFIRMED | 0 | UNK | |||||||
124935146 | 12493514 | 5 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Subcutaneous | 600 MG, UNK | U | 0 | 600 | MG | |||||||
124935146 | 12493514 | 6 | C | HEPARIN | HEPARIN SODIUM | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | |||||||||
124935146 | 12493514 | 7 | C | LOPERAMIDE | LOPERAMIDE | 1 | Unknown | UNK | U | 0 | |||||||||
124935146 | 12493514 | 8 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Unknown | UNK | U | 0 | |||||||||
124935146 | 12493514 | 9 | C | ONDANSETRON | ONDANSETRON | 1 | Oral | 8 MG, UNK | U | 0 | 8 | MG | |||||||
124935146 | 12493514 | 10 | C | TYVERB | LAPATINIB | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124935146 | 12493514 | 1 | Product used for unknown indication |
124935146 | 12493514 | 2 | Product used for unknown indication |
124935146 | 12493514 | 3 | Product used for unknown indication |
124935146 | 12493514 | 4 | Product used for unknown indication |
124935146 | 12493514 | 5 | Product used for unknown indication |
124935146 | 12493514 | 6 | Product used for unknown indication |
124935146 | 12493514 | 7 | Product used for unknown indication |
124935146 | 12493514 | 8 | Product used for unknown indication |
124935146 | 12493514 | 9 | Product used for unknown indication |
124935146 | 12493514 | 10 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124935146 | 12493514 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124935146 | 12493514 | Constipation | |
124935146 | 12493514 | Cough | |
124935146 | 12493514 | Depression | |
124935146 | 12493514 | Diarrhoea | |
124935146 | 12493514 | Dyspnoea exertional | |
124935146 | 12493514 | Fatigue | |
124935146 | 12493514 | Haemoglobin abnormal | |
124935146 | 12493514 | Herpes zoster | |
124935146 | 12493514 | Infected skin ulcer | |
124935146 | 12493514 | Lethargy | |
124935146 | 12493514 | Malaise | |
124935146 | 12493514 | Musculoskeletal stiffness | |
124935146 | 12493514 | Nausea | |
124935146 | 12493514 | Neutropenia | |
124935146 | 12493514 | Neutrophil count abnormal | |
124935146 | 12493514 | Onychalgia | |
124935146 | 12493514 | Peripheral swelling | |
124935146 | 12493514 | Plantar erythema | |
124935146 | 12493514 | Poor quality sleep | |
124935146 | 12493514 | Rash | |
124935146 | 12493514 | Tachycardia | |
124935146 | 12493514 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |